Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > San Diego

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Jan 04, 2024 9:01pm

142 Views

Post# 35811658

RE:RE:San Diego

itndtf,

ONC has develeoped a habit over the years of misleading its investors.

Sad to hear they now also treat investors with disdain in while in direct communication.

I think people should flood MC's mailbox and demand a meaningful plan for how he intends to right this sinking ship.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec